Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Simris Alg AB's share price for the quarter that ended in Mar. 2026 was kr0.0998. Simris Alg AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 1,349.79 Mil. Therefore, Simris Alg AB's market cap for the quarter that ended in Mar. 2026 was kr134.71 Mil.
Simris Alg AB's quarterly market cap
declined
from Sep. 2025 (kr76.89 Mil) to Dec. 2025 (kr36.04 Mil) but then
increased
from Dec. 2025 (kr36.04 Mil) to Mar. 2026 (kr134.71 Mil).
Simris Alg AB's annual market cap
declined
from Dec. 2023 (kr78.32 Mil) to Dec. 2024 (kr47.64 Mil) and
declined
from Dec. 2024 (kr47.64 Mil) to Dec. 2025 (kr36.04 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Simris Alg AB's Enterprise Value for Today is kr152.27 Mil.
Simris Alg AB (OSTO:SIMRIS B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Simris Alg AB Market Cap Related Terms
Simris Alg AB Market Cap Historical Data
* Premium members only.
The historical data trend for Simris Alg AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SIMRIS B vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Simris Alg AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simris Alg AB Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Simris Alg AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Simris Alg AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Simris Alg AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simris Alg AB (OSTO:SIMRIS B) has a Market Cap of kr151.18 Mil as of Jul. 21, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Simris Alg AB and its competitors. According to the industry distribution chart, Simris Alg AB ranks #1130 out of 1423 companies in the Biotechnology industry, placing it in the top 79.4%.
Is Simris Alg AB's Market Cap too high?
Simris Alg AB's current Market Cap is kr151.18 Mil. Based on the distribution chart, Simris Alg AB ranks #1130 out of 1423 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Simris Alg AB has a GF Score™ of 19/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Simris Alg AB's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Simris Alg AB ranks #1130 out of 1423 companies for Market Cap. This places Simris Alg AB in the lower half of its industry. The industry median Market Cap is 111.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 111.61, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Simris Alg AB and its competitors. For the Biotechnology industry, the median Market Cap is 111.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simris Alg AB's current Market Cap is kr151.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simris Alg AB stock overvalued right now?
Based on GuruFocus' analysis, Simris Alg AB (OSTO:SIMRIS B) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.03, compared to a current price of kr0.11 — trading 273.3% above its estimated fair value. The current Market Cap is kr151.18 Mil. Simris Alg AB's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Simris Alg AB (OSTO:SIMRIS B), the current Market Cap is kr151.18 Mil as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simris Alg AB (OSTO:SIMRIS B) Overvalued in 2026?
Based on GuruFocus' analysis, Simris Alg AB stock appears to be overvalued.
The current stock price of kr0.11 is trading 273.3% above its estimated GF Value™ of kr0.03.
GuruFocus considers Simris Alg AB to be Significantly Overvalued.
Key valuation signals for OSTO:SIMRIS B:
Market Cap: kr151.18 Mil
GF Value™: kr0.03 vs. price of kr0.11 (273.3% above fair value)
No single metric tells the full story. See the OSTO:SIMRIS B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
19GF Score
Get the complete analysis for OSTO:SIMRIS B
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SIMRIS B has been successfully added to your 
